Status:
UNKNOWN
Low-Dose Leptin and the Formerly-Obese
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Obesity
Eligibility:
All Genders
19-45 years
Phase:
PHASE3
Brief Summary
Our previous studies have demonstrated that there is substantial metabolic opposition to the maintenance of an altered body weight. Leptin is a protein secreted by fat cells and the circulating concen...
Detailed Description
We demonstrated a substantial metabolic resistance to maintenance of altered body weight. Leptin is secreted by fat cells in circulating concentrations that are directly proportional to fat mass. Lept...
Eligibility Criteria
Inclusion
- Healthy
Exclusion
Key Trial Info
Start Date :
July 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00073242
Start Date
July 1 2000
End Date
July 1 2015
Last Update
June 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia Presbyterian Medical Center
New York, New York, United States, 10032